A panel of advisers for the Centers for Disease Control and Prevention (CDC) will meet on Thursday to consider whether to impose restrictions on the Johnson & Johnson COVID-19 vaccine due to new data on rare blood clot issues, The Washington Post reported. One federal official told the newspaper that nine people have died due to blood clotting complications related to the vaccine. One clinician who spoke with the newspaper said that advisors could either recommend the vaccine for use for certain populations, stop using it altogether or keep its current recommendation unchanged — suggestions that that are subject to final sign-off by CDC Director Rochelle Walensky Rochelle WalenskyBriefing in brief: WH on Biden-Harris 2024 CDC recommends Pfizer, Moderna shots over J&J ​​CDC advisers to consider limits on J&J vaccine over blood clot issues MORE. A preferential recommendation could also be adopted as another solution, in which Moderna and Pfizer-BioNTech vaccines are recommended over the Johnson & Johnson vaccine, a federal official told the Journal. Use of the Johnson & Johnson vaccine was temporarily halted in the U.S. earlier this year.

Source: The Guardian December 16, 2021 19:24 UTC